
Sign up to save your podcasts
Or


A conversation with Dr. Ira Casson (who served on the National Football League’s committee on mild traumatic brain injury and co-authored several of its studies on MTBI) reveals that it may be impossible to assess the value of its six-season study. Despite the author’s defense of the methods used to conduct the research, there’s room for skepticism, both in the light of a New York Times story reporting that over 10% of such injuries may have gone unreported and the study’s assumption that all teams reported all injuries.
We asked the League to make the studies’ first author available for this conversation, and they declined.
By NEJM Group4.5
5656 ratings
A conversation with Dr. Ira Casson (who served on the National Football League’s committee on mild traumatic brain injury and co-authored several of its studies on MTBI) reveals that it may be impossible to assess the value of its six-season study. Despite the author’s defense of the methods used to conduct the research, there’s room for skepticism, both in the light of a New York Times story reporting that over 10% of such injuries may have gone unreported and the study’s assumption that all teams reported all injuries.
We asked the League to make the studies’ first author available for this conversation, and they declined.

7,913 Listeners

321 Listeners

2,053 Listeners

124 Listeners

504 Listeners

299 Listeners

906 Listeners

264 Listeners

3,374 Listeners

113,121 Listeners

89 Listeners

5 Listeners

94 Listeners

518 Listeners

2,592 Listeners

367 Listeners

16,525 Listeners

59 Listeners

31 Listeners

63 Listeners